This is a regulatory disclosure submitted to the BSE Limited and the National Stock Exchange of India Limited, pursuant to Regulation 30 of the SEBI Listing Regulations.

The company, Park Medi World Limited, has incorporated a wholly owned subsidiary named Park Medicity Prayagraj Limited (CIN: U86100DC2026PLC474823). The Certificate of Incorporation was issued by the Ministry of Corporate Affairs on September 08, 2026.

Key Details of the Subsidiary:

  • Name: Park Medicity Prayagraj Limited
  • Industry: Healthcare services
  • Purpose and Object: The subsidiary has been formed to develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh. This project has been awarded to the company under the Public-Private Partnership (PPP) model by the Prayagraj Municipal Corporation, Uttar Pradesh.
  • Ownership Structure: 100% shareholding is held by Park Medi World Limited along with its nominees.
  • Consideration and Cost of Acquisition: The company, along with its nominee, will infuse a subscribed share capital of ₹0.15 crore (Rs. 1,500,000). This is for the acquisition of 1,50,000 equity shares with a face value of ₹10 each.
  • Transaction Nature: The disclosure confirms this is not a related party transaction. The Promoter/Promoter group/group companies have no interest in this entity except for it being a wholly owned subsidiary. The transaction is stated to be at "arm's length."
  • Background: The entity is newly incorporated, so it has no operational history or turnover for the last three years.
  • Governmental Approvals: No governmental or regulatory approvals are required for this incorporation.
  • Timeframe: An indicative time period for completion is not applicable.

The disclosure was made in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. It was signed by Abhishek Kapoor, Company Secretary & Compliance Officer, and has been disseminated on the company's website at https://www.parkhospital.in/.